PT - JOURNAL ARTICLE AU - Turk, Matthew AU - Hayworth, Jacqueline AU - Nevskaya, Tatiana AU - Pope, Janet TI - The frequency of uveitis in patients with adult versus childhood spondyloarthritis AID - 10.1136/rmdopen-2020-001196 DP - 2020 Aug 01 TA - RMD Open PG - e001196 VI - 6 IP - 2 4099 - http://rmdopen.bmj.com/content/6/2/e001196.short 4100 - http://rmdopen.bmj.com/content/6/2/e001196.full SO - RMD Open2020 Aug 01; 6 AB - Objectives This meta-analysis investigated the frequency of ocular involvement in childhood and adult spondyloarthritis (SpA).Methods A systematic review of the literature was conducted. Medline, Web of Science and Cochrane databases were searched upto October 2018 identifying publications related to SpA, including ankylosing spondylitis (AS) with ocular conditions (OC) (uveitis, iritis, retinitis, chorioretinitis and other ocular involvement). The rates of OC were extracted and random effects models estimated their frequency. Heterogeneity was evaluated using I2. Inclusion criteria were studies in SpA of either children or adults who included a frequency of OC.Results 3164 studies were identified, and 41 analysed which included frequencies of uveitis/iritis. Other OC were too infrequent to analyse. A pooled random effects model showed that the prevalence of uveitis was 24% in adult AS (23 studies, 11 943 patients), 10% in adult psoriatic arthritis (PsA) (9 studies, 1817) and 17% in undifferentiated adult SpA (9 studies, 6568 patients). In juveniles with AS, the prevalence of uveitis was 27% (8 studies, 927 patients), in juvenile PsA it was 16% (5 studies, N=498) and in juvenile undifferentiated SpA, uveitis occurred in 7% (2 studies, 1531 patients). In all evaluated SpA subgroups, there were no statistical differences in the frequency of uveitis between juveniles and adults.Conclusions Uveitis in adult versus child-onset SpA is similar in AS but more common in adult-onset undifferentiated SpA, and less frequent in adult-onset PsA compared to child-onset PsA, but the differences were not significant.